Couchara Georgeann, an insider at Danaher Corp (DHR), sold 3,623 shares of the company's stock at a price of $210.44 per share, resulting in a total transaction value of $762,000 on November 9, 2025. Following this transaction, Georgeann retains 3,623 shares of Danaher Corp.
Danaher Corp operates in the Life Sciences Tools & Services industry and is headquartered in Washington, D.C. The company designs, manufactures, and markets a range of professional, medical, industrial, and commercial products and services. It employs 61,000 full-time staff and operates across three segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment focuses on bioprocessing and discovery, while the Life Sciences segment provides instruments and software for studying the fundamental components of life. The Diagnostics segment supplies clinical instruments and services for disease diagnosis and treatment decisions.
The company currently boasts a market capitalisation of $159.3 billion, with a P/E ratio of 45.47 and an EPS of 4.86. Its dividend yield stands at 58.3%. Upcoming earnings reports are scheduled for April 19, 2026, with an estimated EPS of $2.02 and revenue of $6.1 billion, and July 19, 2026, with an estimated EPS of $2.01 and revenue of $6.4 billion.
Insider transactions must be reported to the SEC, offering insight into the actions of company executives and board members. While selling activity by a single insider is one data point, it should be considered alongside other fundamental and technical factors. Investors are advised to examine patterns of insider activity across multiple individuals and time periods, rather than focusing on isolated transactions.